In your trust, how many patients with HER2 breast cancer are currently being treated (in the past 3 months available) with the following products;
Herceptin IV (trastuzumab IV) only
Herceptin SC (trastuzumab SC) only
Perjeta (pertuzumab) combined with Herceptin/Docatexel
Kadcyla (trastuzumab emtansine)
Tyverb (lapatinib)